Abdel SC, Maher CG, Furmage AM, et al. Strengthening the reporting of harms of all interventions in clinical trials. Med J Aust. 2022;217(10):502–4.

Article  Google Scholar 

Polasek TM, Schuck V. Improving the efficiency of clinical pharmacology studies. Clin Pharmacol Drug Dev. 2023;12:771–4.

Article  CAS  PubMed  Google Scholar 

Doogue MP, Polasek TM. The ABCD of clinical pharmacokinetics. Ther Adv Drug Saf. 2013;4:5–7.

Article  PubMed  PubMed Central  Google Scholar 

Pollin W, Perlin S. Psychiatric evaluation of “normal control” volunteers. Am J Psychiatry. 1958;115:129–33.

Article  CAS  PubMed  Google Scholar 

Rosenthal R, Rosnow RL. The volunteer subject. Hum Relat. 1965;18:389–406.

Article  Google Scholar 

Walsh JA, Nash MM. Personality characteristics of volunteers for medical research. Crim Justic Behav. 1978;5:99–116.

Google Scholar 

Cowles M, Davis C. The subject matter of psychology: Volunteers. Br J Soc Psychol. 1987;26:97–102.

Article  Google Scholar 

Cami J, Llorente M, Farre M, et al. Personality of healthy volunteers participating in phase I clinical trials. Pers Individ Differ. 1989;11:1199–200.

Article  Google Scholar 

Ball CJ, McLaren PM, Morrison PJ. The personality structure of ‘normal’ volunteers. Br J Clin Pharmacol. 1993;4:369–71.

Article  Google Scholar 

Berto D, Milleri S, Squassante L, et al. Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies. Eur J Clin Pharmacol. 1996;5:209–13.

Article  Google Scholar 

Tishler C, Apseloff G, Bartholomae S, et al. Are normal healthy research volunteers psychologically healthy? A pilot investigation. Exp Clin Psychopharmacol. 2007;6:539–45.

Article  Google Scholar 

Wei Y, Li H, Wang H, Zhang S, et al. Psychological status of volunteers in a phase I clinical trial assessed by symptom checklist 90 (SCL-90) and Eysenck Personality Questionnaire (EPQ). Med Sci Monit. 2018;24:4968–73.

Article  PubMed  PubMed Central  Google Scholar 

Farre M, Lamas X, Cami J. Sensation seeking amongst healthy volunteers participating in phase I clinical trials. Br J Clin Pharmacol. 1995;39:405–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gustavsson JP, Asberg M. The healthy control subject in psychiatric research: impulsiveness and volunteer bias. Acta Psychiatr Scand. 2007;96:325–8.

Article  Google Scholar 

Pieters MS, Jennekens-Schinkel A, Shoemaker HC. Self-selection for personality variables among healthy volunteers. Br J Clin Pharmacol. 1992;33:101–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Royal Australian and New Zealand College of psychiatrists. Clinical Memorandum Therapeutic use of MDMA for PTSD and psilocybin for treatment resistant depression. 2023. https://www.ranzcp.org/getmedia/0cf57ea2-0bd7-4883-9155-d2ba1958df86/cm-therapeutic-use-of-mdma-for-ptsd-and-psilocybin-for-treatment-resistant-depression.pdf. Accessed Dec 2023.

Webster RK, Weinman J, Rubin GJ. A systematic review of factors that contribute to nocebo effects. Health Psychol. 2016;35(12):1334–55.

Article  PubMed  Google Scholar 

Kööts-Ausmees L, Schmidt M, Esko T, et al. The role of the five factor personality traits in self-reported general health. Eur J Personal. 2016;30(5):492–504.

Article  Google Scholar 

Watson D. Strangers’ ratings of five robust personality factors: Evidence of a surprising convergence with self-report. J Person Soc Psychology. 1989;57(1):120–8.

Article  Google Scholar 

Costa PT, McCrae RR. Neuroticism, somatic complaints, and disease: is the bark worse than the bite? J Pers. 1987;55(2):299–316.

Article  PubMed  Google Scholar 

Jerram KL, Coleman PG. The big five personality traits and reporting of health problems and health behaviour in old age. Br J Health Psychol. 1999;1999(4):181–92.

Article  Google Scholar 

Realo A, Van Middendorp H, Koots-Ausmees L, et al. Role of personality traits in reporting the development of adverse drug reactions: a prospective cohort study of the Estonian general population. BMJ Open. 2018;8:e022428.

Article  PubMed  PubMed Central  Google Scholar 

Almeida L, Falcão A, Vaz-da-Silva M, et al. Personality characteristics of volunteers in Phase 1 studies and likelihood of reporting adverse events. Int J Clin Pharmacol Ther. 2008;46:340–8.

Article  CAS  PubMed  Google Scholar 

Almeida L, Kasdan TB, Nunes T, et al. Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol. 2008;64:575–82.

Article  CAS  PubMed  Google Scholar 

Foster JM, Sanderman R, van der Molen T. Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients. J Asthma. 2008;45:664–9.

Article  PubMed  Google Scholar 

Davis C, Ralevski E, Kennedy S, et al. The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. J Clin Psychopharmacol. 1995;15:347–52.

Article  CAS  PubMed  Google Scholar 

Amare AT, Schubert KO, Tekola-Ayele F, et al. Association of polygenic score for personality traits and response to selective serotonin re-uptake inhibitors in patients with major depressive disorder. Front Psychiatry. 2018;9:65.

Article  PubMed  PubMed Central  Google Scholar 

Xu F. Effect of personality type on pharmacodynamics through changing pharmacokinetics. Med Hypotheses. 2007;69:1131–4.

Article  CAS  PubMed  Google Scholar 

Tishler C, Bartholomae S, Rhodes A. Personality profiles of normal healthy research volunteers: a potential concern for clinical drug trial investigators? Med Hypotheses. 2005;65:1–7.

Article  PubMed  Google Scholar 

Thomas A. The Alternative Model of Personality Disorders (AMPD) from the Perspective of the Five-Factor Model. Psychopathology. 2020;53:149–56.

Article  Google Scholar 

Rucker J, Jafari H, Mantingh T, et al. Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial. BMJ Open. 2021;11(12):e056091.

Article  PubMed  PubMed Central  Google Scholar